Literature DB >> 19339599

Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.

Tianxiang Zhang1, Lifen Zhang, Yong Liang, Athanassios G Siapas, Fu-Ming Zhou, John A Dani.   

Abstract

The dorsal striatum and the nucleus accumbens (NAc) shell of the ventral striatum have similar cellular components and are both richly innervated by dopamine neurons. Despite similarities that extend throughout the striatum, only the NAc shell has a conspicuous increase in basal dopamine upon the initial administration of psychostimulant drugs such as nicotine. As measured by microdialysis, the elevated dopamine in the NAc shell is considered an identifying functional characteristic of addictive drugs. To examine this general functional difference between nicotine's action on the dorsolateral striatum and NAc shell, we directly monitored dopamine release in rat striatal slices using fast-scan cyclic voltammetry. In addition, we separately monitored the in vivo unit firing activity of putative midbrain dopamine neurons from freely moving rats using chronic multiple tetrodes. Nicotine administration increased the firing frequency of dopamine neurons and specifically increased the number and the length of phasic burst firing. The frequency dependence for dopamine release in the dorsolateral striatum and NAc shell is fundamentally different, enabling mainly the NAc shell to capitalize on the nicotine-induced phasic burst firing by dopamine neurons. Although nicotine decreased low-frequency (tonic) dopamine release in both areas, the increased ratio of phasic bursts relative to tonic firing caused by nicotine boosted the basal dopamine concentration predominantly in the NAc shell. By favoring release from bursts while depressing release from tonic signals, nicotine spreads the range of dopamine signaling and effectively increases the signal-to-noise relationship along dopamine afferents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339599      PMCID: PMC2743099          DOI: 10.1523/JNEUROSCI.0261-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

1.  Postnatal development of the dopamine transporter: a quantitative autoradiographic study.

Authors:  C L Coulter; H K Happe; L C Murrin
Journal:  Brain Res Dev Brain Res       Date:  1996-04-30

2.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.

Authors:  F E Pontieri; G Tanda; F Orzi; G Di Chiara
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

Review 3.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

4.  Electron-microscopic study of dopaminergic structures in the medial subdivision of the monkey nucleus accumbens.

Authors:  K Ikemoto; K Satoh; K Kitahama; M Geffard; T Maeda
Journal:  Exp Brain Res       Date:  1996-09       Impact factor: 1.972

Review 5.  The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data.

Authors:  C M Pennartz; H J Groenewegen; F H Lopes da Silva
Journal:  Prog Neurobiol       Date:  1994-04       Impact factor: 11.685

6.  Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo.

Authors:  K Chergui; M F Suaud-Chagny; F Gonon
Journal:  Neuroscience       Date:  1994-10       Impact factor: 3.590

7.  Interplay between facilitation, depression, and residual calcium at three presynaptic terminals.

Authors:  J S Dittman; A C Kreitzer; W G Regehr
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

8.  Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms.

Authors:  M M Rathouz; D K Berg
Journal:  J Neurosci       Date:  1994-11       Impact factor: 6.167

9.  Nicotinic effects on the firing pattern of midbrain dopamine neurons.

Authors:  J Grenhoff; G Aston-Jones; T H Svensson
Journal:  Acta Physiol Scand       Date:  1986-11

10.  Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.

Authors:  S N Haber; H Ryoo; C Cox; W Lu
Journal:  J Comp Neurol       Date:  1995-11-20       Impact factor: 3.215

View more
  80 in total

1.  Flexible optitrode for localized light delivery and electrical recording.

Authors:  S-T Lin; J C Wolfe; J A Dani; W-C Shih
Journal:  Opt Lett       Date:  2012-06-01       Impact factor: 3.776

Review 2.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

3.  α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.

Authors:  Xiomara A Perez; Tanuja Bordia; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2010-08-23       Impact factor: 4.436

4.  Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal.

Authors:  Taryn E Grieder; Olivier George; Huibing Tan; Susan R George; Bernard Le Foll; Steven R Laviolette; Derek van der Kooy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

Review 5.  Targeting nicotinic receptors for Parkinson's disease therapy.

Authors:  Maryka Quik; Tanuja Bordia; Luping Huang; Xiomara Perez
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

6.  The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning.

Authors:  J D Raybuck; T J Gould
Journal:  Neurobiol Learn Mem       Date:  2010-08-19       Impact factor: 2.877

7.  Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Authors:  Xiomara A Perez; J Michael McIntosh; Maryka Quik
Journal:  J Neurochem       Date:  2013-10-13       Impact factor: 5.372

Review 8.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

9.  Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia.

Authors:  Anthony M Downs; Xueliang Fan; Christine Donsante; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2019-01-30       Impact factor: 5.996

Review 10.  Inhibitory Plasticity of Mesocorticolimbic Circuits in Addiction and Mental Illness.

Authors:  Alexey Ostroumov; John A Dani
Journal:  Trends Neurosci       Date:  2018-08-24       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.